| Literature DB >> 32249925 |
Tohid Gharibi1,2,3,4,5, Zohreh Babaloo1,2, Arezoo Hosseini1,2,3,4, Faroogh Marofi1,2, Abbas Ebrahimi-Kalan3,4, Saeed Jahandideh6, Behzad Baradaran1,2.
Abstract
There is ongoing debate on how B cells contribute to the pathogenesis of multiple sclerosis (MS). The success of B-cell targeting therapies in MS highlighted the role of B cells, particularly the antibody-independent functions of these cells such as antigen presentation to T cells and modulation of the function of T cells and myeloid cells by secreting pathogenic and/or protective cytokines in the central nervous system. Here, we discuss the role of different antibody-dependent and antibody-independent functions of B cells in MS disease activity and progression proposing new therapeutic strategies for the optimization of B-cell targeting treatments.Entities:
Keywords: B cells; B-cell-depleting therapies; antibodies; multiple sclerosis
Mesh:
Substances:
Year: 2020 PMID: 32249925 PMCID: PMC7370136 DOI: 10.1111/imm.13198
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397